期刊文献+

甲状腺癌甲基化差异片断的筛选

Isolation of methylative difference DNA fragments in thyroid cancer
下载PDF
导出
摘要 目的筛选甲状腺癌与甲状腺癌旁组织的甲基化差异片段。方法采用甲基敏感性代表性差异分析(MS-RDA)方法,用甲基化敏感性内切酶消化甲状腺癌及癌旁组织基因组DNA,连上接头制备扩增子后,进行两轮消减杂交,筛选甲状腺癌与癌旁组织的甲基化差异片段。结果经过两轮消减杂交后,筛选出3个低甲基化差异片段,2个高甲基化差异片断。筛选出的低甲基化差异片段C913位于BC029276基因上,该基因编码一种rRNA结合蛋白,可能与肿瘤有关。另外2个低甲基化差异片段C915与C917尚未见相关结构和功能的报道。两个高甲基化差异片断与已知基因同源性在20%-35%之间。5个片断均为新的甲基化差异片断。结论在甲状腺癌组织中存在异常甲基化,筛选出的甲基化差异片断有助于进一步了解异常甲基化在甲状腺癌发生发展中的作用。 Objective To investigate the aberrantly methylated status in human thyroid cancer. Methods Methylation - sensitive - representational difference analysis (MS - RDA) technique was employed to the primary thyroid cancer and adjacent noncancerous tissue. Results Following two sueeessive competitive hybridization, 3 hypo - and 2 hypermethylated DNA fragments was identified. One of these 3 hypomethylated fragments, C913, is located in BC029276 gene which encode a rRNA binding protein and may be associated with neoplasm. The strueture and function of the other two, C915 and C917, is not clear at present. The 2 hypermethylated fragments, (2919, C922, showed low homology with any known gene in GenBank. Conclusion Aberrant methylation may involve in development of thyroid cancer.
出处 《湘南学院学报(医学版)》 2009年第2期1-4,共4页 Journal of Xiangnan University(Medical Sciences)
基金 湖南省卫生厅重点课题(Z02-09)
关键词 甲基化 甲状腺癌 甲基敏感性代表性差异分析 Methylation Thyroid cancer MS-RDA
  • 相关文献

参考文献7

  • 1Toshikazu Ushijima, Keiiehirou Morimura, Yoko Hosoya, et al. Establishment of methylation - sensitive - representational difference analysis and isolation of hypo- and hyper- methylated genomic fragmets in mouse liver tumors[J]. Proc Natl Acad Sci, 1997, 94: 2284- 2289
  • 2彭正良,曹仁贤.甲状腺肿瘤相关基因甲基化研究进展[J].国外医学(生理病理科学与临床分册),2005,25(2):126-129. 被引量:3
  • 3Hoque MO, Rosenbaum E, Westra WH, et al. Quantitative Assessment of Promoter Methylation Profiles in Thyroid Neoplasms [J]. J Clin Endocrinol Metab, 2005,19:1119
  • 4Xing M, Cohen Y, Mambo E, et al. Early occurrence of RASSF1A hypermethylation and its mutual exclusion with BRAF mutation in thyroid tumorigenesis [ J ]. Cancer Res, 2004, 64 (5) : 1664 - 1668
  • 5Ogasawara S, Maesawa C, Yamamoto M, et al. Disruption of cell- type- specific methylation at the Maspin gene promoter is frequently involved in undifferentiated thyroid cancers[J]. Oncogene, 2004, 23(5):1117- 1124
  • 6Kazuaki Miyamoto, Kiyoshi Asada, Takashi Fukutomi, et al.Methylation- associated silencing of heparan sulfate D - glu- cosaminyl 3 - O - sulfotransferase - 2 (3 - OST - 2) in human breast, colon, lung and Pancreatic cancers [ J ]. Oncogene, 2003, 22 : 274 - 280
  • 7Milko Kermekchiev, Lidia Ivanova. Ribin, a Protein encoded by a message complementary to proliferation[J]. Molecular and Cell Biology, 2001, 17 (6) :8255 - 8263

二级参考文献15

  • 1Merlo A, Herman JG, Mao L, et al. 5 'CpG island methylation is associated with transcription silencing of the tumor suppressor pl6/CDKN2/MTS1 in human cancers[J]. Nat Med,1995,1 (7) :686-692.
  • 2Boltze C, Zack S, Quednow C,et al. Hypermethylation of the CDKN2/pl61NK4A promotor in thyroid carcinogenesis [J]. Pathol Res Pract,2003,199 ( 6 ) : 399 -404.
  • 3Schagdarsuregin U, Gimm O, Cuong Hoang-Vu C, et al. Frequent epigenetic silencing of the CpG island promoter of RASSF1 A in thyroid carcinoma[J]. Cancer Res ,2002.62 ( 12 ):3698-3701.
  • 4Xing M, Cohen Y, Mambo E, et al. Early ocurrence of RASSF1A hypermethylation and its mutual exclusion with BRAF mutation in thyroid tumorigenesis[ J ]. Cancer Res ,2004,64 ( 6 ) : 1664-1668.
  • 5Graft JR, Greenberg VE, Herman JG,et al. Distinct patterns of Ecadherin CpG island methylation in papillary, follicular, Hurthle's cell, and poorly differentiated human thyroid carcinoma[ J]. Cancer Res, 1998,58 ( 10 ) :2063-2066.
  • 6Maass N, Hojo T,Ueding M,et al. Expression of the tumor suppressor gene Maspin in human pancreatic cancers[J]. Clin Cancer Res,2001,7(4) :812-817.
  • 7Sood AK, Fletcher MS, Gruman LM, et al. The paradoxical expression of Maspin in ovarian carcinoma [ J ]. Clin Cancer Res, 2002,8( 9 ) :2924-2932.
  • 8Futscher BW, Oshiro MM, Wozniak R J, et al. Role for DNA methylation in the control of cell type specific maspin expression [J]. Nat Genet,2002,31 (2) : 175-179.
  • 9Ogasawara S, Maesawa C, Yamamoto M, et al. Disruption of cell-type-specific methylation at the Maspin gene promoter is frequently involved in undifferentiated thyroid cancers[J]. Oncogene,2004,23(5) :1117-1124.
  • 10Gopalakrishnan M, Venkataraman M, Yatin M, et al. Restoration of iodide uptake in dedifferentiated thyroid carcinoma: relationship to human Na^+/I^- symporter gene methylation status[J]. J Clin Endocrinol Metab ,1999,84 (7) :2449-2457.

共引文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部